Literature DB >> 10356018

Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading.

L Smeeth1, A Haines, S Ebrahim.   

Abstract

Mesh：

Year:  1999        PMID： 10356018      PMCID： PMC1115910          DOI： 10.1136/bmj.318.7197.1548

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  24 in total

Review 1.  Strategies for the management of hypercholesterolaemia: a systematic review of the cost-effectiveness literature.

Authors:  S Morris; A McGuire; J Caro; D Pettitt
Journal:  J Health Serv Res Policy       Date:  1997-10

Review 2.  Confidence intervals for the number needed to treat.

Authors:  D G Altman
Journal:  BMJ       Date:  1998-11-07

3.  An assessment of clinically useful measures of the consequences of treatment.

Authors:  A Laupacis; D L Sackett; R S Roberts
Journal:  N Engl J Med       Date:  1988-06-30       Impact factor: 91.245

4.  Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Authors:  S Yusuf; R Peto; J Lewis; R Collins; P Sleight
Journal:  Prog Cardiovasc Dis       Date:  1985 Mar-Apr       Impact factor: 8.194

Review 5.  The statistical basis of meta-analysis.

Authors:  J L Fleiss
Journal:  Stat Methods Med Res       Date:  1993       Impact factor: 3.021

6.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

7.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

8.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

Authors: 
Journal:  N Engl J Med       Date:  1998-11-05       Impact factor: 91.245

9.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

10.  Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?

Authors:  C D Naylor; E Chen; B Strauss
Journal:  Ann Intern Med       Date:  1992-12-01       Impact factor: 25.391
View more
  58 in total

1.  Do not resuscitate decisions. Rigid discussion process before making these decisions may cause distress.

Authors:  T Downes; J Liddle
Journal:  BMJ       Date:  2001-01-13

2.  Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? Studies included in meta-analysis had heterogenous, not homogenous, results.

Authors:  C Cates
Journal:  BMJ       Date:  2000-04-29

3.  Numbers needed to treat derived from meta-analysis. Are an absurdity.

Authors:  B G Charlton
Journal:  BMJ       Date:  1999-10-30

4.  Disease impact number and population impact number: population perspectives to measures of risk and benefit.

Authors:  R F Heller; A J Dobson
Journal:  BMJ       Date:  2000-10-14

Review 5.  Evaluation of large scale clinical trials and their application to usual practice.

Authors:  A M Tonkin
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

Review 6.  Interferon in relapsing-remitting multiple sclerosis.

Authors:  G P Rice; B Incorvaia; L Munari; G Ebers; C Polman; R D'Amico; G Filippini
Journal:  Cochrane Database Syst Rev       Date:  2001

7.  Missing the point (estimate)? Confidence intervals for the number needed to treat.

Authors:  Nicholas J Barrowman
Journal:  CMAJ       Date:  2002-06-25       Impact factor: 8.262

Review 8.  Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.

Authors:  Ilke Sipahi; Sara M Debanne; Douglas Y Rowland; Daniel I Simon; James C Fang
Journal:  Lancet Oncol       Date:  2010-06-11       Impact factor: 41.316

Review 9.  Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials.

Authors:  João Costa; Margarida Borges; Cláudio David; António Vaz Carneiro
Journal:  BMJ       Date:  2006-04-03

10.  Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.

Authors:  Yoon K Loke; Sonal Singh; Curt D Furberg
Journal:  CMAJ       Date:  2008-12-10       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.